Lactobacillus rhamnosus MP108

Product description

✅ Here are the key achievements of Lactobacillus rhamnosus MP108:
  • EFSA-QPS System Permission
  • Approved probiotic strain for Chinese food, including infant and children formulas
  • Recognized as an approved food ingredient in Taiwan
  • Validated through strict safety assessments: Acute Toxicity Test, Genetic Toxicity Test, 90-Day Oral Toxicity Test
  • Clinically Proven
  • Protected in 11 global patents, including USA, CN, TW
  • Published in 9 international scientific papers (3 SCI Papers)
  • Awarded in NutraIngredient Asia Award Finalist: Editors Award for Infant and Child Nutrition Initiative in 2021.
  • Awarded in World Food Innovation Awards Finalist: Best Ingredient Innovation in 2021.
  • Awarded in Nutrition & Functional Food Asia Pacific (NFFA) Infant Nutrition Ingredient Award in 2021.
→ See more: https://lihi.cc/EcL9l/IIN_MP108
Read more

Specifications

Categories Anti-allergens; Clinical trials; Probiotics
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Supplied from Taiwan, China
Product Applications Food Supplements; Infant Nutrition/ Baby Foods & Infant Formula; Natural Products
Product Certifications Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Quality assurance; Sustainable; Traceable

More products from Glac biotech Co., Ltd.

View all our products (21)

Products from other suppliers

Lactobacillus rhamnosus MP108

Contact information

Address

Email

Telephone

Website

View all contact information